Anti-ErbB 2 antibody
| Name | Anti-ErbB 2 antibody |
|---|---|
| Supplier | Abcam |
| Catalog | ab2428 |
| Prices | $400.00 |
| Sizes | 1 ml |
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Applications | IHC-P IHC-F IP WB ICC/IF ICC/IF ICC/IF |
| Species Reactivities | Mouse, Rat, Human |
| Antigen | Synthetic peptide (Human) (C terminal) |
| Blocking Peptide | ErbB 2 peptide |
| Description | Rabbit Polyclonal |
| Gene | ERBB2 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
ab2428 at a 1:200 dilution staining SK-BR-3 whole cell lysate.
Western blot of whole cell lysates of cultured cells, used at a concentration of 1:1000, incubated overnight at 4C, and visualized with an HRP conjugated secondary, with a chemilumenescent detection method. Review by Todd Gocken submitted 20 July 2004
ab2428 staining ErbB 2 in human breast cancer, tissue section by Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections). Tissue underwent fixation in formaldehyde, heat mediated antigen retrieval in Citrate buffer pH 6.0 and blocking in 10% serum for 1 hour at 20°C.The primary antibody was diluted, 1/100 in TBS and incubated with sample for 12 hours at 4°C. A Biotin conjugated goat polyclonal to rabbit IgG was used undiluted, as secondary. Left hand-side image show staining with ab2428 and developed using DAB detection system while right hand-side shows Isotype control staining with anti-rabbit IgG and DAB.See Abreview
Product References
Plasma membrane proteomics of human breast cancer cell lines identifies potential - Plasma membrane proteomics of human breast cancer cell lines identifies potential
Ziegler YS, Moresco JJ, Tu PG, Yates JR 3rd, Nardulli AM. PLoS One. 2014 Jul 16;9(7):e102341.
miR-21 Expression in Cancer Cells may Not Predict Resistance to Adjuvant - miR-21 Expression in Cancer Cells may Not Predict Resistance to Adjuvant
Nielsen BS, Balslev E, Poulsen TS, Nielsen D, Moller T, Mortensen CE, Holmstrom K, Hogdall E. Front Oncol. 2014 Aug 15;4:207.
Bcl3 selectively promotes metastasis of ERBB2-driven mammary tumors. - Bcl3 selectively promotes metastasis of ERBB2-driven mammary tumors.
Wakefield A, Soukupova J, Montagne A, Ranger J, French R, Muller WJ, Clarkson RW. Cancer Res. 2013 Jan 15;73(2):745-55.
.
Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in - Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in
Deng Z, Zhen Z, Hu X, Wu S, Xu Z, Chu PK. Biomaterials. 2011 Jul;32(21):4976-86.
Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer - Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer
Piggott L, Omidvar N, Marti Perez S, Eberl M, Clarkson RW. Breast Cancer Res. 2011 Sep 14;13(5):R88.
Vertebrate Lrig3-ErbB interactions occur in vitro but are unlikely to play a role - Vertebrate Lrig3-ErbB interactions occur in vitro but are unlikely to play a role
Abraira VE, Satoh T, Fekete DM, Goodrich LV. PLoS One. 2010 Feb 1;5(2):e8981.
Involvement of 9-O-Acetyl GD3 ganglioside in Mycobacterium leprae infection of - Involvement of 9-O-Acetyl GD3 ganglioside in Mycobacterium leprae infection of
Ribeiro-Resende VT, Ribeiro-Guimaraes ML, Lemes RM, Nascimento IC, Alves L, Mendez-Otero R, Pessolani MC, Lara FA. J Biol Chem. 2010 Oct 29;285(44):34086-96.
t10c12 conjugated linoleic acid suppresses HER2 protein and enhances apoptosis in - t10c12 conjugated linoleic acid suppresses HER2 protein and enhances apoptosis in
Flowers M, Thompson PA. PLoS One. 2009;4(4):e5342.
t10,c12-Conjugated linoleic acid stimulates mammary tumor progression in - t10,c12-Conjugated linoleic acid stimulates mammary tumor progression in
Meng X, Shoemaker SF, McGee SO, Ip MM. Carcinogenesis. 2008 May;29(5):1013-21.